- Hot topics of lipidology, metabolic syndrome, HDL-C, new lipid-lowering drugs2004 | Faculty of Physical Education and Sport
- LDL-cholesterol: the lower the better! We need a new lipid lowering drugs? Focus on alirokumab (Praluent)2015 | First Faculty of Medicine
- Do we need new lipid lowering drugs?2007 | First Faculty of Medicine
- New lipid lowering drugs2021 | First Faculty of Medicine
- Non-lipid lowering related effects of lipid lowering drugsPublication without faculty affiliation
- Pharmacogenetics and pharmacogenomics of lipid-lowering drugs2017 | First Faculty of Medicine
- An Analysis of the Theoretical Exposition of Chronically Prescribed Lipid Lowering Drugs to the Insured2002 | Publication without faculty affiliation
- New lipid lowering drugs: why and how to treat dyslipidemia in (near) future?2010 | First Faculty of Medicine
- Analysis of Theoretical Exposition to Lipid Lowering DrugsPublication without faculty affiliation
- Combination of lipid-lowering drugs: how to continue after the ACCORD trial?2010 | First Faculty of Medicine
- Lipid-lowering drugs in patients with chronic kidney disease2016 | First Faculty of Medicine
- Lipid-lowering drugs and their indication in patients with chronic kidney disease2015 | First Faculty of Medicine
- Hot topics of lipidology, metabolic syndrome, HDL-C, new lipid-lowering drugs2004 | First Faculty of Medicine
- Hyperlipoproteinemias2009 | First Faculty of Medicine
- Clinical studies, evidence based medicina expectations and reality2009 | First Faculty of Medicine
- Treatment of HLP and DLP in 20092009 | First Faculty of Medicine
- Metabolic syndrome, residual risk and AIP2009 | First Faculty of Medicine
- Metabolic syndrome, residual risk and AIP2009 | Publication without faculty affiliation
- Familial hypercholesterolemia +12015 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Atherosclerosis2010 | First Faculty of Medicine
- Pharmacotherapy of HLP and DLP2010 | First Faculty of Medicine
- Monoclonal antibodies in the treatment of dyslipidemia and cardiovascular risk reduction2015 | First Faculty of Medicine
- Once a few words to study VATARO2016 | First Faculty of Medicine
- Treatment of HLP and DLP in diabetes2010 | First Faculty of Medicine
- Treatment of dyslipidemia in heart failure2013 | First Faculty of Medicine
- Contemporary and modern treatment of hyperlipoproteinemia2016 | First Faculty of Medicine
- Alirocumab, Praluent: Clinical studies: An overwiev2016 | First Faculty of Medicine
- Some comments on the 2016 ESC/EAS guidelines for diagnosing and treating dyslipidaemias +12017 | First Faculty of Medicine